Intervacc (Sweden) Today
| IVACC Stock | SEK 2.52 0.14 5.26% |
Performance0 of 100
| Odds Of DistressOver 68
|
Intervacc is selling for under 2.52 as of the 27th of November 2024; that is 5.26 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.46. Intervacc has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Intervacc AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Intervacc AB , a biotechnology company, engages in the research and development of veterinary vaccines using recombinant proteins for animal health. The company has a collaboration with the Karolinska Institute. Intervacc operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. The company has 50.49 M outstanding shares. More on Intervacc AB
Moving together with Intervacc Stock
| 0.79 | CAMX | Camurus AB | PairCorr |
| 0.87 | HNSA | Hansa Biopharma AB | PairCorr |
| 0.9 | NANOFS | Nanoform Finland Plc | PairCorr |
Moving against Intervacc Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Intervacc Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Intervacc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Intervacc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | JanIngmar Flock |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Intervacc AB (IVACC) is traded on Stockholm Exchange in Sweden and employs 13 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.02 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Intervacc's market, we take the total number of its shares issued and multiply it by Intervacc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Intervacc AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 50.49 M outstanding shares.
Intervacc AB has accumulated about 148.98 M in cash with (25.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.97, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Intervacc Probability Of Bankruptcy
Ownership AllocationIntervacc AB has a total of 50.49 Million outstanding shares. 30% of Intervacc AB outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Intervacc Ownership Details
Intervacc AB Risk Profiles
Although Intervacc's alpha and beta are two of the key measurements used to evaluate Intervacc's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.36 | |||
| Standard Deviation | 4.74 | |||
| Variance | 22.51 | |||
| Risk Adjusted Performance | (0.08) |
Intervacc Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Intervacc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Intervacc Corporate Directors
| Newton Aguiar | Director | Profile | |
| Bert Urlings | Director | Profile | |
| Stefan Stahl | Independent Director | Profile | |
| Marianne Hansson | Director | Profile |
Additional Tools for Intervacc Stock Analysis
When running Intervacc's price analysis, check to measure Intervacc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intervacc is operating at the current time. Most of Intervacc's value examination focuses on studying past and present price action to predict the probability of Intervacc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intervacc's price. Additionally, you may evaluate how the addition of Intervacc to your portfolios can decrease your overall portfolio volatility.